Abiomed Inc (NASDAQ:ABMD)

268.25
Delayed Data
As of Feb 21
 -2.23 / -0.82%
Today’s Change
114.28
Today|||52-Week Range
274.00
+43.14%
Year-to-Date
Abiomed Hits New 52-Week High: 4 Factors Driving the Stock
Feb 19 / Zacks.com - Paid Partner Content
Abiomed's Extended FDA Nod for Impella Boosts Women Health
Feb 14 / Zacks.com - Paid Partner Content
Abiomed's Extended FDA Nod for Impella Refines PCI Diagnosis
Feb 16 / Zacks.com - Paid Partner Content
Quest Diagnostics Banks on Alliances, Long-Term View Solid
Feb 08 / Zacks.com - Paid Partner Content